{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:00:20Z","timestamp":1773486020626,"version":"3.50.1"},"reference-count":38,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Context: Abnormal plasma nonesterified fatty acid (NEFA) metabolism may play a role in the development of type 2 diabetes.<\/jats:p>\n                  <jats:p>Objectives: Our objectives were to demonstrate whether there is a defect in insulin-mediated suppression of plasma NEFA appearance (RaNEFA) and oxidation (OxNEFA) during enhanced intravascular triacylglycerol lipolysis early in the natural history of type 2 diabetes, and if so, to determine whether other mechanisms than reduced insulin-mediated suppression of intracellular lipolysis are involved.<\/jats:p>\n                  <jats:p>Design: These are cross-sectional studies.<\/jats:p>\n                  <jats:p>Setting: The studies were performed at an academic clinical research center.<\/jats:p>\n                  <jats:p>Participants: Nine healthy subjects with both parents with type 2 diabetes (FH+) and nine healthy subjects with no first-degree relatives with type 2 diabetes (FH\u2212) with similar anthropometric features were included in the studies.<\/jats:p>\n                  <jats:p>Interventions: Pancreatic clamps and iv infusion of stable isotopic tracers ([1,1,2,3,3-2H5]-glycerol and [U-13C]-palmitate or [1,2-13C]-acetate) were performed while intravascular triacylglycerol lipolysis was simultaneously clamped by iv infusion of heparin plus Intralipid at low (fasting) and high insulin levels. Oral nicotinic acid (NA) was used to inhibit intracellular lipolysis.<\/jats:p>\n                  <jats:p>Main Outcome Measures: RaNEFA and OxNEFA were determined.<\/jats:p>\n                  <jats:p>Results: During heparin plus Intralipid infusion at high plasma insulin levels, and despite similar intravascular lipolytic rates, FH+ had higher RaNEFA and OxNEFA than FH\u2212 (RaNEFA: 17.4 \u00b1 6.3 vs. 9.2 \u00b1 4.2; OxNEFA: 4.5 \u00b1 1.8 vs. 2.3 \u00b1 1.5 \u03bcmol\/kg lean body mass\/min), independent of NA intake, gender, age, and body composition. In the presence of NA, insulin-mediated suppression of RaNEFA was still observed in FH\u2212, but not in FH+.<\/jats:p>\n                  <jats:p>Conclusions: Increased RaNEFA and OxNEFA during intravascular lipolysis at high insulin levels occur early in the natural history of type 2 diabetes.<\/jats:p>","DOI":"10.1210\/jc.2007-1670","type":"journal-article","created":{"date-parts":[[2008,1,8]],"date-time":"2008-01-08T22:34:08Z","timestamp":1199831648000},"page":"837-844","source":"Crossref","is-referenced-by-count":49,"title":["Impaired Plasma Nonesterified Fatty Acid Tolerance Is an Early Defect in the Natural History of Type 2 Diabetes"],"prefix":"10.1210","volume":"93","author":[{"given":"P.","family":"Brassard","sequence":"first","affiliation":[{"name":"Department of Medicine (P.B., F.F., F.L., A.B., J.-P.B., A.C.C.), Division of Endocrinology, Centre hospitalier universitaire de Sherbrooke, Universite\u0301 de Sherbrooke, Sherbrooke, Que\u0301bec, Canada J1H 5N4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Frisch","sequence":"additional","affiliation":[{"name":"Department of Medicine (P.B., F.F., F.L., A.B., J.-P.B., A.C.C.), Division of Endocrinology, Centre hospitalier universitaire de Sherbrooke, Universite\u0301 de Sherbrooke, Sherbrooke, Que\u0301bec, Canada J1H 5N4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lavoie","sequence":"additional","affiliation":[{"name":"Department of Medicine (P.B., F.F., F.L., A.B., J.-P.B., A.C.C.), Division of Endocrinology, Centre hospitalier universitaire de Sherbrooke, Universite\u0301 de Sherbrooke, Sherbrooke, Que\u0301bec, Canada J1H 5N4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cyr","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (D.C., R.D.), Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bourbonnais","sequence":"additional","affiliation":[{"name":"Department of Medicine (P.B., F.F., F.L., A.B., J.-P.B., A.C.C.), Division of Endocrinology, Centre hospitalier universitaire de Sherbrooke, Universite\u0301 de Sherbrooke, Sherbrooke, Que\u0301bec, Canada J1H 5N4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. C.","family":"Cunnane","sequence":"additional","affiliation":[{"name":"Division of Genetics, Universite\u0301 de Sherbrooke, Research Center on Aging (S.C.C.), Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. W.","family":"Patterson","sequence":"additional","affiliation":[{"name":"Division of Sherbrooke, Que\u0301bec, Canada J1K 2R1; and the Center for Human Nutrition (B.W.P.), Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Drouin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (D.C., R.D.), Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Baillargeon","sequence":"additional","affiliation":[{"name":"Department of Medicine (P.B., F.F., F.L., A.B., J.-P.B., A.C.C.), Division of Endocrinology, Centre hospitalier universitaire de Sherbrooke, Universite\u0301 de Sherbrooke, Sherbrooke, Que\u0301bec, Canada J1H 5N4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C.","family":"Carpentier","sequence":"additional","affiliation":[{"name":"Department of Medicine (P.B., F.F., F.L., A.B., J.-P.B., A.C.C.), Division of Endocrinology, Centre hospitalier universitaire de Sherbrooke, Universite\u0301 de Sherbrooke, Sherbrooke, Que\u0301bec, Canada J1H 5N4"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613443816800_R1","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2337\/diabetes.50.7.1612","article-title":"Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects.","volume":"50","author":"Boden","year":"2001","journal-title":"Diabetes"},{"key":"2020071613443816800_R2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2337\/diabetes.48.2.358","article-title":"Rapid impairment of skeletal muscle glucose transport\/phosphorylation by free fatty acids in humans.","volume":"48","author":"Roden","year":"1999","journal-title":"Diabetes"},{"key":"2020071613443816800_R3","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1152\/ajpendo.00033.2003","article-title":"Mechanisms of the free fatty acid-induced increase in hepatic glucose production","volume":"284","author":"Lam","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6 Pt 1","key":"2020071613443816800_R4","first-page":"E1055","article-title":"Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation","volume":"276","author":"Carpentier","year":"1999","journal-title":"Am J Physiol"},{"key":"2020071613443816800_R5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocr Rev"},{"key":"2020071613443816800_R6","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2337\/diabetes.52.6.1485","article-title":"Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetes.","volume":"52","author":"Carpentier","year":"2003","journal-title":"Diabetes"},{"key":"2020071613443816800_R7","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.2337\/diabetes.52.10.2461","article-title":"A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.","volume":"52","author":"Kashyap","year":"2003","journal-title":"Diabetes"},{"key":"2020071613443816800_R8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0026-0495(03)00102-1","article-title":"Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes.","volume":"52","author":"Storgaard","year":"2003","journal-title":"Metabolism"},{"key":"2020071613443816800_R9","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1210\/jc.2002-021430","article-title":"Insulin secretion and cellular glucose metabolism after prolonged low-grade Intralipid infusion in young men.","volume":"88","author":"Jensen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613443816800_R10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0140-6736(92)92814-V","article-title":"Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.","volume":"340","author":"Martin","year":"1992","journal-title":"Lancet"},{"key":"2020071613443816800_R11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-131-1-199907060-00006","article-title":"Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes.","volume":"131","author":"Axelsen","year":"1999","journal-title":"Ann Intern Med"},{"key":"2020071613443816800_R12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S0007114598001585","article-title":"Lipoprotein lipase and the disposition of dietary fatty acids.","volume":"80","author":"Fielding","year":"1998","journal-title":"Br J Nutr"},{"key":"2020071613443816800_R13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2337\/diabetes.52.3.675","article-title":"Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy.","volume":"52","author":"Miles","year":"2003","journal-title":"Diabetes"},{"issue":"2 Pt 1","key":"2020071613443816800_R14","first-page":"E241","article-title":"Effects of an oral and intravenous fat load on adipose tissue and forearm lipid metabolism","volume":"39","author":"Evans","year":"1999","journal-title":"Am J Physiol"},{"key":"2020071613443816800_R15","first-page":"S5","article-title":"Diagnosis and classification of diabetes mellitus","volume-title":"Diabetes Care","author":"American Diabetes Association","year":"2004"},{"key":"2020071613443816800_R16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/oxfordjournals.aje.a113987","article-title":"Physical activity assessment methodology in the Five-City Project.","volume":"121","author":"Sallis","year":"1985","journal-title":"Am J Epidemiol"},{"key":"2020071613443816800_R17","doi-asserted-by":"crossref","first-page":"E849","DOI":"10.1152\/ajpendo.00073.2005","article-title":"On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans","volume":"289","author":"Carpentier","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071613443816800_R18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.38.12.1595","article-title":"Insulin regulation of lipolysis in nondiabetic and IDDM subjects.","volume":"38","author":"Jensen","year":"1989","journal-title":"Diabetes"},{"key":"2020071613443816800_R19","first-page":"2085","article-title":"Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis.","volume":"86","author":"Gravholt","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613443816800_R20","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2337\/diabetes.52.7.1641","article-title":"What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean?","volume":"52","author":"Mittendorfer","year":"2001","journal-title":"Diabetes"},{"key":"2020071613443816800_R21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/db06-0822","article-title":"Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period.","volume":"56","author":"Bickerton","year":"2007","journal-title":"Diabetes"},{"key":"2020071613443816800_R22","doi-asserted-by":"crossref","first-page":"E693","DOI":"10.1152\/ajpendo.00423.2006","article-title":"Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans","volume":"292","author":"Carpentier","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071613443816800_R23","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1172\/JCI112682","article-title":"Palmitate and glycerol kinetics during brief starvation in normal weight young adult and elderly subjects.","volume":"78","author":"Klein","year":"1986","journal-title":"J Clin Invest"},{"key":"2020071613443816800_R24","first-page":"235","article-title":"Measurement of substrate oxidation","author":"Wolfe","year":"1992","journal-title":"In: Radioactive and stable isotope tracers in biomedicine: principles and practice of kinetic analysis. New-York: Wiley-Liss;"},{"key":"2020071613443816800_R25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2337\/diabetes.47.10.1609","article-title":"Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects.","volume":"47","author":"Boden","year":"1998","journal-title":"Diabetes"},{"key":"2020071613443816800_R26","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.2337\/diabetes.49.12.2102","article-title":"Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise.","volume":"49","author":"Blaak","year":"2000","journal-title":"Diabetes"},{"key":"2020071613443816800_R27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1152\/jappl.1983.55.2.628","article-title":"Calculation of substrate oxidation rates in vivo from gaseous exchange.","volume":"55","author":"Frayn","year":"1983","journal-title":"J Appl Physiol"},{"key":"2020071613443816800_R28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","article-title":"PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect.","volume":"9","author":"Tunaru","year":"2003","journal-title":"Nat Med"},{"key":"2020071613443816800_R29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2337\/db06-1680","article-title":"Direct free fatty acid uptake into human adipocytes in vivo\u2013relation to body fat distribution.","volume":"56","author":"Shadid","year":"2007","journal-title":"Diabetes"},{"key":"2020071613443816800_R30","doi-asserted-by":"crossref","first-page":"E789","DOI":"10.1152\/ajpendo.00557.2004","article-title":"Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes","volume":"288","author":"Ravikumar","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071613443816800_R31","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.2337\/diabetes.54.9.2668","article-title":"Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens.","volume":"54","author":"Barrows","year":"2005","journal-title":"Diabetes"},{"key":"2020071613443816800_R32","doi-asserted-by":"crossref","first-page":"E732","DOI":"10.1152\/ajpendo.00409.2006","article-title":"Dietary fatty acids make a rapid and substantial contribution to VLDL-triacylglycerol in the fed state","volume":"292","author":"Heath","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071613443816800_R33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2337\/diabetes.53.3.521","article-title":"Systemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glycerol and free fatty acids.","volume":"53","author":"Miles","year":"2004","journal-title":"Diabetes"},{"key":"2020071613443816800_R34","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2337\/diab.42.11.1567","article-title":"Postprandial free fatty acid kinetics are abnormal in upper body obesity.","volume":"42","author":"Roust","year":"1993","journal-title":"Diabetes"},{"key":"2020071613443816800_R35","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2337\/diabetes.48.8.1600","article-title":"Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans\u2013a H-1-C-13 nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.","volume":"48","author":"Perseghin","year":"1999","journal-title":"Diabetes"},{"key":"2020071613443816800_R36","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa031314","article-title":"Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.","volume":"350","author":"Petersen","year":"2004","journal-title":"N Engl J Med"},{"key":"2020071613443816800_R37","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2337\/db06-0783","article-title":"Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients.","volume":"56","author":"Befroy","year":"2007","journal-title":"Diabetes"},{"key":"2020071613443816800_R38","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2362.2002.00945.x","article-title":"Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner.","volume":"32","author":"Panarotto","year":"2002","journal-title":"Eur J Clin Invest"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/3\/837\/9055442\/jcem0837.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/3\/837\/9055442\/jcem0837.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T20:32:39Z","timestamp":1594931559000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/3\/837\/2598492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-1670","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1105136.561040","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,1]]}}}